Your browser is no longer supported. Please, upgrade your browser.
FMI Foundation Medicine, Inc. daily Stock Chart
FMI [NASD]
Foundation Medicine, Inc.
Index- P/E- EPS (ttm)-4.51 Insider Own2.40% Shs Outstand36.65M Perf Week-8.72%
Market Cap2.67B Forward P/E- EPS next Y-3.19 Insider Trans-40.23% Shs Float15.27M Perf Month-8.89%
Income-161.50M PEG- EPS next Q-1.10 Inst Own33.80% Short Float15.44% Perf Quarter9.65%
Sales152.90M P/S17.44 EPS this Y-38.30% Inst Trans-0.65% Short Ratio7.07 Perf Half Y71.78%
Book/sh0.87 P/B83.62 EPS next Y26.00% ROA-101.80% Target Price79.50 Perf Year125.23%
Cash/sh1.95 P/C37.34 EPS next 5Y- ROE-207.70% 52W Range31.70 - 87.10 Perf YTD6.67%
Dividend- P/FCF- EPS past 5Y15.50% ROI-175.50% 52W High-17.28% Beta-0.11
Dividend %- Quick Ratio1.70 Sales past 5Y70.40% Gross Margin44.20% 52W Low127.29% ATR4.61
Employees682 Current Ratio1.90 Sales Q/Q69.80% Oper. Margin- RSI (14)44.20 Volatility7.61% 6.04%
OptionableYes Debt/Eq1.89 EPS Q/Q-3.30% Profit Margin- Rel Volume0.37 Prev Close72.75
ShortableYes LT Debt/Eq1.89 EarningsMar 07 AMC Payout- Avg Volume333.53K Price72.05
Recom2.50 SMA20-5.64% SMA50-5.95% SMA20028.62% Volume86,694 Change-0.96%
Jan-29-18Initiated Goldman Neutral $73
Sep-16-15Downgrade Wells Fargo Outperform → Market Perform
Jul-30-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Mar-10-15Initiated UBS Neutral $50
Aug-01-14Initiated Tigress Financial Neutral
Apr-18-18 07:45AM  How BTCY Could Look a Lot Like SRPT in a Year's Time ACCESSWIRE
Apr-17-18 07:00AM  Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call Business Wire +8.89%
Apr-11-18 07:00AM  Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies Business Wire
Apr-09-18 08:54AM  Cancer Treatment Centers of America and Foundation Medicine Launch Joint Educational Campaign to Raise Consumer Awareness of Precision Medicine Approaches in Cancer Care PR Newswire +5.17%
Apr-04-18 11:19AM  Does Foundation Medicine Incs (NASDAQ:FMI) Debt Level Pose A Problem? Simply Wall St. +5.86%
Mar-30-18 07:00AM  Foundation Medicine Announces Commercial Availability of FoundationOne CDx, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagnostics Business Wire
Mar-29-18 07:30AM  Research Report Identifies Beazer Homes, Extra Space Storage, Foundation Medicine, Kennametal, Midstates Petroleum, and Corporate Office Properties Trust with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-23-18 12:48PM  Foundation Medicine Inc (NASDAQ:FMI): Will The Growth Last? Simply Wall St.
Mar-20-18 07:00AM  Blog Exposure - Foundation Medicine Collaborated with Chugai for Commercialization of FoundationOne CDx(TM) in Japan ACCESSWIRE
Mar-18-18 10:19PM  Foundation Medicine Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDx Across All Solid Tumors Business Wire
Mar-16-18 06:45PM  Medicare Will Cover Genetic Cancer Testing, With Caveats Forbes
02:00AM  Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx in Japan Business Wire
01:16AM  Edited Transcript of FMI earnings conference call or presentation 7-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-13-18 04:05PM  Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit Business Wire
Mar-08-18 07:04PM  Foundation Medicine (FMI) Q4 2017 Earnings Conference Call Transcript Motley Fool
06:30AM  Foundation Medicine to Present at Cowen and Companys 38th Annual Healthcare Conference Business Wire
Mar-07-18 04:35PM  Foundation Medicine reports 4Q loss Associated Press
04:01PM  Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook Business Wire
12:30PM  Foundation Medicine, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-18 06:30AM  3 Growth Stocks That Could Put Netflix's Returns to Shame Motley Fool
Feb-19-18 04:31PM  Does Foundation Medicine Incs (NASDAQ:FMI) Past Performance Indicate A Weaker Future? Simply Wall St.
Feb-15-18 04:56PM  Foundation Medicine Set For 'Material Upside,' Cowen Says In Bullish Initiation Benzinga +5.11%
Feb-13-18 06:30AM  Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2017 Financial Results and Conference Call Business Wire
Feb-05-18 01:04PM  3 Things to Really Like About Bristol-Myers Squibb's Q4 Earnings Results Motley Fool
Jan-30-18 07:00AM  Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clinical Trial Enrollment Business Wire
Jan-26-18 07:35AM  Report: Exploring Fundamental Drivers Behind Lands' End, Foundation Medicine, Benefitfocus, Corporate Office Properties Trust, Forest City Realty Trust, and United Dominion Realty Trust New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jan-23-18 01:35PM  Forget Bitcoin, You're Better Off Buying These 3 Stocks Motley Fool
Jan-16-18 07:00AM  Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizers Oncology Portfolio Business Wire
Jan-08-18 06:30AM  Foundation Medicine Reports Preliminary 2017 Results Business Wire
Jan-03-18 04:01PM  Foundation Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference Business Wire
12:18PM  What does Foundation Medicine Incs (NASDAQ:FMI) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
Dec-14-17 01:23PM  ETFs with exposure to Foundation Medicine, Inc. : December 14, 2017 Capital Cube
Dec-11-17 12:50PM  Foundation Medicine CEO talks the future of cancer treatm... CNBC Videos
Dec-06-17 07:00AM  Foundation Medicine and Collaborators to Present New Data at the American Society of Hematology (ASH) Annual Meeting that Supports Use of FoundationOne®Heme to Advance Personalized Medicine in Blood Cancers Business Wire
Dec-05-17 10:15AM  Company News For Dec 5, 2017 Zacks -5.38%
Dec-04-17 08:09PM  [$$] Ex-Google Ventures Chief Bill Maris Hires Partner for Venture Firm The Wall Street Journal
06:00AM  Ex-Googler Maris Adds Partner From Foundation Medicine Bloomberg
01:40AM  Roche's Foundation Medicine wins FDA blessing for new cancer test Reuters
01:33AM  Roche's Foundation Medicine wins FDA blessing for new cancer test Reuters
Dec-02-17 10:30AM  The FDA Ushers In a New Era in Cancer Treatment Motley Fool
Dec-01-17 05:23PM  Charting the Market: Foundation Medicine's Test Flags 324 Cancer Genes Barrons.com +17.67%
04:33PM  This Biotech Launched To A Record High On Cancer Test Approval Investor's Business Daily
04:30PM  Why Ambarella, Foundation Medicine, and Mylan Jumped Today Motley Fool
04:16AM  FDA Approves Foundation Medicine's FoundationOne CDx Diagnostic Test for Solid Tumors Benzinga
Nov-30-17 11:15PM  FDA Approves Foundation Medicines FoundationOne CDx, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics Business Wire +5.24%
06:34PM  Foundation's cancer gene test gets U.S. FDA and Medicare nod Reuters
05:00PM  Foundation Medicine gets nod from FDA and Medicare for cancer test Reuters
Nov-29-17 11:35AM  ETFs with exposure to Foundation Medicine, Inc. : November 29, 2017 Capital Cube
Nov-17-17 11:55AM  ETFs with exposure to Foundation Medicine, Inc. : November 17, 2017 Capital Cube
Nov-07-17 08:33AM  Options Traders Expect Huge Moves in Foundation Medicine (FMI) Stock Zacks -6.62%
Nov-06-17 11:35AM  ETFs with exposure to Foundation Medicine, Inc. : November 6, 2017 Capital Cube
Nov-03-17 10:08AM  Foundation Medicine, Inc. :FMI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017 Capital Cube
03:41AM  Edited Transcript of FMI earnings conference call or presentation 1-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-02-17 09:00PM  The Precision Medicine Stock That's Revolutionizing Cancer Treatment Motley Fool +19.50%
Nov-01-17 05:27PM  Foundation Medicine reports 3Q loss Associated Press -6.56%
04:01PM  Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights Business Wire
Oct-22-17 12:15PM  3 Healthcare Stocks for Your Radar Motley Fool
Oct-16-17 07:00AM  Foundation Medicine to Present Validation for FoundationOne CDx, a Comprehensive Genomic Profiling Assay for Advancing Precision Cancer Care Business Wire
Oct-12-17 06:30AM  Foundation Medicine Announces Timing for Third Quarter 2017 Financial Results and Conference Call Business Wire
Oct-10-17 06:00PM  Is This the Best Precision Medicine Stock to Buy? Motley Fool
05:00PM  Foundation Medicine Appoints Tom Civik as Chief Commercial Officer Business Wire
Oct-03-17 07:01PM  Lifshitz & Miller LLP Announces Investigation of Foundation Medicine, Inc., Health Insurance Innovations, Inc., Juno Therapeutics, Inc., LendingClub Corporation, MiMedx Group, Inc., Ooma, Inc. and SCANA Corporation PR Newswire
Oct-02-17 07:00AM  Foundation Medicine Receives Approval from the State of New York for its FoundationACT Liquid Biopsy Assay Business Wire
Sep-27-17 08:17AM  Foundation Medicine, Inc. breached its 50 day moving average in a Bearish Manner : FMI-US : September 27, 2017 Capital Cube
Sep-25-17 10:50PM  FOUNDATION MEDICINE 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit Against Foundation Medicine, Inc. - (FMI) Business Wire
04:19PM  DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
04:03PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Foundation Medicine, Inc. (FMI) Business Wire
01:04PM  DEADLINE TOMORROW: Khang & Khang LLP Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm GlobeNewswire
10:55AM  DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Foundation Medicine, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2017 - FMI ACCESSWIRE
10:16AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Foundation Medicine, Inc. (FMI) & Lead Plaintiff Deadline: September 26, 2017 ACCESSWIRE
Sep-22-17 10:50PM  FOUNDATION MEDICINE 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Foundation Medicine, Inc. - (FMI) Business Wire
08:33PM  Reminder Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Looming Deadline in the Class Action Lawsuit Against Foundation Medicine, Inc. (FMI) Business Wire
Sep-21-17 01:24PM  SHAREHOLDER REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
Sep-20-17 04:04PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Foundation Medicine, Inc. - FMI PR Newswire
03:30PM  6-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:22AM  FMI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Foundation Medicine, Inc. and a Lead Plaintiff Deadline of September 26, 2017 ACCESSWIRE
10:15AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Foundation Medicine, Inc. (FMI) & Lead Plaintiff Deadline - September 26, 2017 ACCESSWIRE
Sep-19-17 10:50PM  FOUNDATION MEDICINE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Foundation Medicine, Inc. - (FMI) GlobeNewswire
04:53PM  ONE WEEK DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm GlobeNewswire
12:13PM  DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Foundation Medicine, Inc. (Nasdaq: FMI) To Contact The Firm GlobeNewswire
11:43AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Foundation Medicine, Inc. Shareholders of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2017 - FMI ACCESSWIRE
10:30AM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Foundation Medicine, Inc. Investors (FMI) Business Wire
Sep-18-17 08:08PM  8-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:05AM  The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Foundation Medicine, Inc. Shareholders and a Lead Plaintiff Deadline of September 26, 2017 (FMI) ACCESSWIRE
10:15AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Foundation Medicine, Inc. (FMI) & Lead Plaintiff Deadline - September 26, 2017 ACCESSWIRE
Sep-15-17 11:28PM  UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:50PM  FOUNDATION MEDICINE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Foundation Medicine, Inc. - (FMI) GlobeNewswire
11:27AM  FMI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Foundation Medicine, Inc. and a Lead Plaintiff Deadline of September 26, 2017 ACCESSWIRE
Sep-14-17 05:23PM  DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:30AM  INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Foundation Medicine, Inc. Investors (FMI) Business Wire
Sep-13-17 06:15PM  ETFs with exposure to Foundation Medicine, Inc. : September 13, 2017 Capital Cube
11:30AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Foundation Medicine, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2017 - FMI ACCESSWIRE
10:14AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Foundation Medicine, Inc. (FMI) & Lead Plaintiff Deadline: September 26, 2017 ACCESSWIRE
Sep-12-17 03:59PM  DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:30AM  The Klein Law Firm Reminds Investors of Commencement of a Class Action on Behalf of Foundation Medicine, Inc. Shareholders and a Lead Plaintiff Deadline of September 26, 2017 (FMI) ACCESSWIRE
Sep-11-17 03:56PM  DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
02:28PM  Foundation Medicine, Inc. :FMI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017 Capital Cube
10:57AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Foundation Medicine, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2017 - FMI ACCESSWIRE
Sep-08-17 11:59PM  DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
10:50PM  FOUNDATION MEDICINE SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Foundation Medicine, Inc. - (FMI) Business Wire
Foundation Medicine, Inc. provides various molecular information products in the United States. The company's molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic insights about each patient's individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted therapies and immunotherapies. It provides clinical products, such as FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and sarcomas; Foundation Assay for Circulating Tumor; FoundationFocus CDxBRCA, a diagnostic assay to aid in identifying women with ovarian cancer; and FoundationOne CDx, a diagnostic assay for solid tumors. The company also offers FoundationCORE, a knowledgebase to publish scientific and medical advances, and foster relationships throughout the oncology community. In addition, it has strategic collaboration agreements with F. Hoffmann-La Roche Ltd.; and Genentech, Inc. Foundation Medicine, Inc. has a collaboration with The European Organisation for Research and Treatment of Cancer to advance precision medicine using comprehensive genomic profiling to facilitate clinical trial enrollment. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts. Foundation Medicine, Inc. is a subsidiary of Roche Holdings, Inc.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ryan JasonChief Financial OfficerApr 16Sale74.303,449256,26152,573Apr 18 04:08 PM
Miller Vincent A.Chief Medical OfficerApr 16Sale74.023,283243,00870,088Apr 18 04:07 PM
Pellini Michael JDirectorApr 16Sale74.653,500261,275110,711Apr 18 04:08 PM
Doherty Michael JHead of Product DevelopmentApr 03Sale72.40214583,962Apr 05 04:15 PM
Ryan JasonChief Financial OfficerApr 03Sale72.4017256,022Apr 05 04:15 PM
Pellini Michael JDirectorApr 03Sale70.2813,659959,955114,211Apr 05 04:14 PM
Hesslein Robert W.SVP and General CounselApr 02Option Exercise7.122,34416,689109,308Apr 03 04:11 PM
Nallicheri MelanieChief Business OfficerApr 02Sale74.881,25393,82568,019Apr 03 04:13 PM
Ryan JasonChief Financial OfficerApr 02Sale76.236,139467,95956,023Apr 03 04:13 PM
Hesslein Robert W.SVP and General CounselApr 02Sale74.881,585118,685107,723Apr 03 04:11 PM
Miller Vincent A.Chief Medical OfficerApr 02Sale74.882,883215,87173,371Apr 03 04:11 PM
Fiedler KonstantinChief Operating OfficerApr 02Sale74.8835826,80727,829Apr 03 04:10 PM
Doherty Michael JHead of Product DevelopmentApr 02Sale74.878,190613,18583,964Apr 03 04:09 PM
Ryan JasonChief Financial OfficerMar 15Option Exercise29.6315,000444,45057,083Mar 19 04:17 PM
Pellini Michael JDirectorMar 15Sale78.293,500274,015127,870Mar 19 04:18 PM
Ryan JasonChief Financial OfficerMar 15Sale78.2615,0001,173,90049,230Mar 19 04:17 PM
Miller Vincent A.Chief Medical OfficerFeb 20Option Exercise29.946,811203,92180,133Mar 12 04:15 PM
Miller Vincent A.Chief Medical OfficerFeb 20Option Exercise6.4712,00877,703102,697Feb 22 04:03 PM
Miller Vincent A.Chief Medical OfficerFeb 20Sale76.8732,0082,460,45573,322Feb 22 04:03 PM
Miller Vincent A.Chief Medical OfficerFeb 20Sale85.0016,8111,428,93563,322Mar 12 04:15 PM
Ryan JasonChief Financial OfficerFeb 15Option Exercise29.6315,000444,45064,230Feb 20 04:05 PM
Ryan JasonChief Financial OfficerFeb 15Sale67.5315,0001,012,95049,230Feb 20 04:05 PM
Pellini Michael JDirectorFeb 15Sale67.6917,3241,172,662131,370Feb 20 04:04 PM
Cox TroyChief Executive OfficerFeb 15Sale67.229,012605,787215,333Feb 20 04:04 PM
Kafka Steven J.President & COOFeb 13Sale61.5529,7911,833,63631,570Feb 15 04:06 PM
Kafka Steven J.President & COOFeb 07Sale70.1323,0641,617,47861,361Feb 09 04:04 PM
Cox TroyChief Executive OfficerFeb 07Sale70.1326,7131,873,383224,345Feb 09 04:03 PM
Miller Vincent A.Chief Medical OfficerJan 29Option Exercise4.164,40018,30497,722Jan 31 04:03 PM
Miller Vincent A.Chief Medical OfficerJan 29Sale75.004,400330,00093,322Jan 31 04:03 PM
Miller Vincent A.Chief Medical OfficerJan 22Option Exercise0.8417,18714,437110,509Jan 24 04:19 PM
Miller Vincent A.Chief Medical OfficerJan 22Sale70.2717,1871,207,73093,322Jan 24 04:19 PM
Miller Vincent A.Chief Medical OfficerJan 17Option Exercise0.845,5344,64998,856Jan 18 04:04 PM
Pellini Michael JDirectorJan 17Sale65.5210,150665,028148,694Jan 18 04:04 PM
Miller Vincent A.Chief Medical OfficerJan 17Sale65.395,534361,86893,322Jan 18 04:04 PM
Miller Vincent A.Chief Medical OfficerJan 16Option Exercise0.845,4084,54398,730Jan 18 04:04 PM
Ryan JasonChief Financial OfficerJan 16Option Exercise29.6320,000592,60069,230Jan 18 04:05 PM
Pellini Michael JDirectorJan 16Sale64.1927,1381,741,988158,844Jan 18 04:04 PM
Ryan JasonChief Financial OfficerJan 16Sale64.3821,0351,354,23349,230Jan 18 04:05 PM
Miller Vincent A.Chief Medical OfficerJan 16Sale65.269,221601,76293,322Jan 18 04:04 PM
Hesslein Robert W.SVP and General CounselJan 16Sale64.3018,0211,158,75098,343Jan 18 04:03 PM
Kafka Steven J.President & COOJan 16Sale65.714,148272,56584,425Jan 18 04:03 PM
Kafka Steven J.President & COOJan 03Sale64.002,257144,44888,573Jan 03 05:18 PM
Nallicheri MelanieChief Business OfficerJan 02Sale64.001,49495,61657,777Jan 03 05:19 PM
Ryan JasonChief Financial OfficerJan 02Sale64.002,336149,50450,265Jan 03 05:19 PM
Kafka Steven J.President & COOJan 02Sale64.0015710,04890,830Jan 03 05:18 PM
Miller Vincent A.Chief Medical OfficerJan 02Sale64.002,349150,33697,135Jan 03 05:18 PM
Hesslein Robert W.SVP and General CounselJan 02Sale64.001,864119,296116,364Jan 03 05:18 PM
Pellini Michael JDirectorDec 13Sale61.7148,7463,008,116185,982Dec 15 04:03 PM
JONES EVAN/ FADirectorDec 13Sale62.051,40086,87017,652Dec 15 04:02 PM
Kafka Steven J.President & COODec 07Option Exercise5.3488,361471,644141,883Dec 11 04:03 PM
Kafka Steven J.President & COODec 07Sale61.6688,3615,448,33990,987Dec 11 04:03 PM
Kafka Steven J.President & COODec 06Option Exercise4.165,77424,02096,761Dec 07 04:03 PM
Pellini Michael JDirectorDec 06Sale58.1120,9471,217,230237,228Dec 07 04:04 PM
Kafka Steven J.President & COODec 06Sale58.575,774338,18390,987Dec 07 04:03 PM
JONES EVAN/ FADirectorDec 06Sale57.8860034,72819,052Dec 07 04:03 PM
Ryan JasonChief Financial OfficerDec 05Option Exercise6.1421,726133,30271,289Dec 07 04:05 PM
Ryan JasonChief Financial OfficerDec 05Sale61.2621,7261,330,93552,601Dec 07 04:05 PM
Pellini Michael JDirectorDec 05Sale61.479,053556,488258,175Dec 07 04:04 PM
Miller Vincent A.Chief Medical OfficerDec 05Sale61.1720,0001,223,40099,984Dec 07 04:04 PM
JONES EVAN/ FADirectorDec 05Sale60.945,900359,54619,652Dec 07 04:03 PM
Ryan JasonChief Financial OfficerNov 02Sale50.009,731486,55052,601Nov 06 04:02 PM
Kafka Steven J.President & COOOct 13Sale44.623,361149,96890,987Oct 16 04:10 PM
Ryan JasonChief Financial OfficerOct 12Sale45.051,15251,89862,332Oct 16 04:10 PM
Pellini Michael JDirectorOct 02Sale38.804,349168,741267,228Oct 04 04:04 PM
Ryan JasonChief Financial OfficerOct 02Sale38.803,154122,37563,484Oct 04 04:05 PM
Miller Vincent A.Chief Medical OfficerOct 02Sale38.802,944114,227119,984Oct 04 04:03 PM
Nallicheri MelanieChief Business OfficerOct 02Sale38.805,440211,07259,271Oct 04 04:04 PM
Hesslein Robert W.SVP and General CounselOct 02Sale38.802,16584,002118,228Oct 04 04:02 PM
Kafka Steven J.President & COOOct 02Sale38.803,201124,19994,348Oct 04 04:02 PM
Daly DavidChief Commercial OfficerAug 09Option Exercise22.2446,8721,042,433163,133Aug 10 04:06 PM
Pellini Michael JDirectorAug 09Sale39.5230,0001,185,600275,077Aug 10 04:06 PM
Daly DavidChief Commercial OfficerAug 09Sale39.5046,8721,851,444116,261Aug 10 04:06 PM
Yeshwant KrishnaDirectorAug 08Sale40.014,800192,0485,786Aug 10 04:07 PM
Yeshwant KrishnaDirectorAug 04Option Exercise24.2113,385324,05119,171Aug 08 04:04 PM
Yeshwant KrishnaDirectorAug 04Sale36.8518,072665,9535,786Aug 08 04:04 PM
Kafka Steven J.President & COOJul 14Sale39.1511,781461,22697,549Jul 17 04:01 PM
Ryan JasonChief Financial OfficerJul 13Sale39.775,084202,19166,638Jul 17 04:02 PM
Miller Vincent A.Chief Medical OfficerJul 06Sale38.845,408210,047122,928Jul 07 04:03 PM
Pellini Michael JDirectorJul 06Sale38.8415,856615,847305,077Jul 07 04:03 PM
Ryan JasonChief Financial OfficerJul 06Sale38.846,683259,56871,722Jul 07 04:04 PM
Kafka Steven J.President & COOJul 06Sale38.847,398287,338109,330Jul 07 04:02 PM
Hesslein Robert W.SVP and General CounselJul 06Sale38.845,070196,919120,393Jul 07 04:02 PM
Daly DavidChief Commercial OfficerJul 06Sale38.846,316245,313116,261Jul 07 04:01 PM
Kafka Steven J.President & COOJul 05Sale38.9812,310479,844116,728Jul 07 04:02 PM
Hesslein Robert W.SVP and General CounselJun 08Option Exercise5.157,03336,196125,463Jun 12 04:21 PM
Ryan JasonChief Financial OfficerJun 02Sale40.005,573222,92078,405Jun 06 04:33 PM
Daly DavidChief Commercial OfficerJun 01Sale38.3055521,257122,577Jun 05 04:01 PM
Hesslein Robert W.SVP and General CounselMay 12Sale33.871,00934,175118,430May 16 04:06 PM